| James Miller Wilson V, MD | |
|
3280 E Lanark Dr, Meridian, ID 83642-5982 | |
| (208) 377-4400 | |
| (208) 377-4416 |
| Full Name | James Miller Wilson V |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 3280 E Lanark Dr, Meridian, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730487042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | M-16498 (Idaho) | Primary |
| Entity Name | Alliance Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568413920 PECOS PAC ID: 3971544685 Enrollment ID: O20050512000561 |
News Archive
After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography (MDCT) scans by participating in a one day dose optimization workshop provided by the Royal Australian and New Zealand College of Radiologists and supported by the local state health department, according to a study in the August issue of the Journal of the American College of Radiology.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
No one needs to explain to the people who have experienced it the danger posed by methicillin-resistant Staphylococcus aureus, the antibiotic-defying bacterium commonly known as MRSA. No one needs to explain to the people who have experienced it the danger posed by methicillin-resistant Staphylococcus aureus, the antibiotic-defying bacterium commonly known as MRSA.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Miller Wilson V, MD Po Box 191050, Boise, ID 83719-1050 Ph: () - | James Miller Wilson V, MD 3280 E Lanark Dr, Meridian, ID 83642-5982 Ph: (208) 377-4400 |
News Archive
After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications announced that its Healthcare Division, Spacelabs Healthcare, has been awarded a one-year $13.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Defense Supply Center Philadelphia Medical Supplier Operations Directorate to provide patient monitoring systems, sub-systems, training and consumables.
Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography (MDCT) scans by participating in a one day dose optimization workshop provided by the Royal Australian and New Zealand College of Radiologists and supported by the local state health department, according to a study in the August issue of the Journal of the American College of Radiology.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
No one needs to explain to the people who have experienced it the danger posed by methicillin-resistant Staphylococcus aureus, the antibiotic-defying bacterium commonly known as MRSA. No one needs to explain to the people who have experienced it the danger posed by methicillin-resistant Staphylococcus aureus, the antibiotic-defying bacterium commonly known as MRSA.
› Verified 3 days ago
Kristina Miles, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 3277 E Louise Dr Ste 200, Meridian, ID 83642 Phone: 208-463-3000 | |
Mrs. Anne E. Riffle, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3653 N. Locust Grove Road, Meridian, ID 83646 Phone: 208-338-5437 Fax: 208-939-9811 | |
Robert F Adams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 520 S Eagle Rd, Meridian, ID 83642 Phone: 208-336-9188 | |
Joshua Edwin Albright, Pediatrics Medicare: Medicare Enrolled Practice Location: 1620 S Celebration Ave, Meridian, ID 83642 Phone: 208-884-1030 | |
Lisa M. Barker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1620 S Celebration Ave, Meridian, ID 83642 Phone: 208-884-1030 | |
Dr. Brian C Birch, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2921 S Meridian Rd, Meridian, ID 83642 Phone: 208-297-7847 Fax: 208-203-0097 | |
Susan C Kim, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3280 E Lanark Dr, Meridian, ID 83642 Phone: 208-377-4400 Fax: 208-377-4416 |